XML 80 R27.htm IDEA: XBRL DOCUMENT v3.24.0.1
Stock-based Compensation Plans (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity
The following table summarizes stock option activity for the twelve months ended December 31, 2023 and 2022 under the 2019 Plan:
OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of January 1, 20233,791,688 $11.33 
Granted2,810,564 $1.70 
Exercised— $— 
Forfeited or expired(406,112)$8.52 
Outstanding as of December 31, 20236,196,140 $7.15 8.14$185,169 
Options vested and expected to vest as of December 31, 20236,196,140 $7.15 8.14$185,169 
Options exercisable as of December 31, 20232,534,017 $11.33 7.19$12,381 
OptionsWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Outstanding as of January 1, 20222,157,460 $13.54 
Granted1,886,263 $8.73 
Exercised(852)$5.67 
Forfeited or expired(251,183)$10.79 
Outstanding as of December 31, 20223,791,688 $11.33 8.35$375 
Options vested and expected to vest as of December 31, 20223,791,688 $11.33 8.35$375 
Options exercisable as of December 31, 20221,398,490 $13.33 7.50$— 
Schedule of Valuation Assumptions Used The following are the underlying assumptions used in the Black-Scholes-Merton option pricing model to determine the fair value of stock options granted to employees and to non-employees under this stock plan:
20232022
Risk-free interest rate3.98%2.09%
Expected dividend yield0%0%
Expected volatility96.1%97.8%
Expected term of options (years)6.06.0
Schedule of Stock-based Compensation Expense for Stock Awards Recognized
Total stock-based compensation expense for all stock awards recognized in the accompanying audited consolidated statements of operations is as follows (in thousands):
 Year
 Ended December 31,
 20232022
Research and development$3,398 $3,219 
General and administrative3,704 4,710 
Total$7,102 $7,929